上尿路尿路上皮癌中肾输尿管根治性切除术联合淋巴结清扫的研究进展

刘智艳, 任靖文, 安云昭, 等. 上尿路尿路上皮癌中肾输尿管根治性切除术联合淋巴结清扫的研究进展[J]. 临床泌尿外科杂志, 2024, 39(11): 1014-1018. doi: 10.13201/j.issn.1001-1420.2024.11.014
引用本文: 刘智艳, 任靖文, 安云昭, 等. 上尿路尿路上皮癌中肾输尿管根治性切除术联合淋巴结清扫的研究进展[J]. 临床泌尿外科杂志, 2024, 39(11): 1014-1018. doi: 10.13201/j.issn.1001-1420.2024.11.014
LIU Zhiyan, REN Jingwen, AN Yunzhao, et al. Research progress in radical nephroureterectomy combined with lymph node dissection in upper tract urothelial carcinoma[J]. J Clin Urol, 2024, 39(11): 1014-1018. doi: 10.13201/j.issn.1001-1420.2024.11.014
Citation: LIU Zhiyan, REN Jingwen, AN Yunzhao, et al. Research progress in radical nephroureterectomy combined with lymph node dissection in upper tract urothelial carcinoma[J]. J Clin Urol, 2024, 39(11): 1014-1018. doi: 10.13201/j.issn.1001-1420.2024.11.014

上尿路尿路上皮癌中肾输尿管根治性切除术联合淋巴结清扫的研究进展

  • 基金项目:
    国家自然科学基金(No:82260157)
详细信息

Research progress in radical nephroureterectomy combined with lymph node dissection in upper tract urothelial carcinoma

More Information
  • 上尿路尿路上皮癌(upper tract urothelial carcinoma,UTUC)是尿路上皮肿瘤中少见的疾病,根治性肾输尿管切除术(radical nephroureterectomy,RNU)加膀胱袖状切除术是目前治疗UTUC的金标准,但是否同期行淋巴结清扫(lymph node dissection,LND)仍存有争议,因此本文就LND在UTUC中的意义、范围、数量、并发症等方面的研究进展作一综述。
  • 加载中
  • [1]

    Rouprêt M, Babjuk M, Burger M, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update[J]. Eur Urol, 2021, 79(1): 62-79. doi: 10.1016/j.eururo.2020.05.042

    [2]

    Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30. doi: 10.3322/caac.21387

    [3]

    中国医师协会泌尿外科医师分会肿瘤专业委员会, 中国医师协会泌尿外科, 医师分会上尿路尿路上皮癌(CUDA-UTUC)协作组. 上尿路尿路上皮癌诊断与治疗中国专家共识[J]. 中华泌尿外科杂志, 2018, 39(7): 485-488.

    [4]

    Califano G, Ouzaid I, Verze P, et al. Immune checkpoint inhibition in upper tract urothelial carcinoma[J]. World J Urol, 2021, 39(5): 1357-1367. doi: 10.1007/s00345-020-03502-7

    [5]

    Dobé TR, Califano G, von Rundstedt FC, et al. Postoperative chemotherapy bladder instillation after radical nephroureterectomy: results of a European survey from the young academic urologist urothelial cancer group[J]. Eur Urol Open Sci, 2020, 22: 45-50. doi: 10.1016/j.euros.2020.10.003

    [6]

    Collà Ruvolo C, Nocera L, Stolzenbach LF, et al. Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma[J]. Eur Urol Oncol, 2021, 4(5): 792-801. doi: 10.1016/j.euo.2020.11.005

    [7]

    Kondo T, Nakazawa H, Ito F, et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract[J]. Urology, 2007, 69(2): 265-269. doi: 10.1016/j.urology.2006.10.014

    [8]

    Matin SF, Sfakianos JP, Espiritu PN, et al. Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates[J]. J Urol, 2015, 194(6): 1567-1574. doi: 10.1016/j.juro.2015.06.077

    [9]

    Winer AG, Vertosick EA, Ghanaat M, et al. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma[J]. Urol Oncol, 2017, 35(4): 151. e9-151151. e15. doi: 10.1016/j.urolonc.2016.11.002

    [10]

    Zhai TS, Jin L, Zhou Z, et al. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy[J]. BMC Cancer, 2019, 19(1): 1207. doi: 10.1186/s12885-019-6364-z

    [11]

    Abe T, Shinohara N, Harabayashi T, et al. The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study[J]. BJU Int, 2008, 102(5): 576-580. doi: 10.1111/j.1464-410X.2008.07673.x

    [12]

    Cho KS, Choi HM, Koo K, et al. Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy[J]. J Korean Med Sci, 2009, 24(4): 674-678. doi: 10.3346/jkms.2009.24.4.674

    [13]

    Mason RJ, Kassouf W, Bell DG, et al. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience[J]. Urology, 2012, 79(4): 840-845. doi: 10.1016/j.urology.2011.11.058

    [14]

    Hsieh HC, Wang CL, Chen CS, et al. The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy[J]. PLoS One, 2022, 17(12): e0278038. doi: 10.1371/journal.pone.0278038

    [15]

    Abe T, Shinohara N, Muranaka M, et al. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: Multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes[J]. Eur J Surg Oncol, 2010, 36(11): 1085-1091. doi: 10.1016/j.ejso.2010.08.134

    [16]

    Ouzzane A, Colin P, Ghoneim TP, et al. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract(UTUC)treated by nephroureterectomy[J]. World J Urol, 2013, 31(1): 189-197. doi: 10.1007/s00345-012-0983-1

    [17]

    Burger M, Shariat SF, Fritsche HM, et al. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study[J]. World J Urol, 2011, 29(4): 465-472. doi: 10.1007/s00345-011-0705-0

    [18]

    Roscigno M, Shariat SF, Margulis V, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy[J]. J Urol, 2009 181(6): 2482-2489. doi: 10.1016/j.juro.2009.02.021

    [19]

    Brausi MA, Gavioli M, De Luca G, et al. Retroperitoneal lymph node dissection(RPLD)in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma(TCC)of the upper urinary tract: impact on survival[J]. Eur Urol, 2007, 52(5): 1414-1418. doi: 10.1016/j.eururo.2007.04.070

    [20]

    Kondo T, Tanabe K. Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract[J]. Int J Urol, 2012, 19(8): 710-721. doi: 10.1111/j.1442-2042.2012.03009.x

    [21]

    Miyake H, Hara I, Gohji K, et al. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract[J]. Br J Urol, 1998, 82(4): 494-498. doi: 10.1046/j.1464-410X.1998.00800.x

    [22]

    单祖卷, 肖宇, 王锦锐, 等. 模板化淋巴结清扫术在上尿路尿路上皮癌中价值及安全性的初步研究[J]. 临床泌尿外科杂志, 2023, 38(10): 766-771. https://lcmw.whuhzzs.com/article/doi/10.13201/j.issn.1001-1420.2023.10.008

    [23]

    Lughezzani G, Jeldres C, Isbarn H, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma[J]. Urology, 2010, 75(1): 118-124. doi: 10.1016/j.urology.2009.07.1296

    [24]

    Ishiyama Y, Kondo T, Kubota S, et al. Therapeutic benefit of lymphadenectomy for older patients with urothelial carcinoma of the upper urinary tract: a propensity score matching study[J]. Jpn J Clin Oncol, 2021, 51(5): 802-809. doi: 10.1093/jjco/hyaa256

    [25]

    Bobjer J, Gerdtsson A, Abrahamsson J, et al. Location of retroperitoneal lymph node metastases in upper tract urothelial carcinoma: results from a prospective lymph node mapping study[J]. Eur Urol Open Sci, 2023, 57: 37-44. doi: 10.1016/j.euros.2023.09.010

    [26]

    Dłubak A, Karwacki J, Logoń K, et al. Lymph node dissection in upper tract urothelial carcinoma: current status and future perspectives[J]. Curr Oncol Rep, 2023, 25(11): 1327-1344. doi: 10.1007/s11912-023-01460-y

    [27]

    张艳辉, 韩彦华, 段高静. 胃肠道恶性肿瘤术后淋巴漏原因分析及处理对策[J]. 中国现代普通外科进展, 2016, 19(7): 576-577, 580.

    [28]

    李翀, 孙雄, 张鹏, 等. 腹部手术后淋巴漏的研究进展[J]. 腹部外科, 2021, 34(3): 184-188.

    [29]

    Lee Z, Cadillo-Chavez R, Lee DI, et al. The technique of single stage pure robotic nephroureterectomy[J]. J Endourol, 2013, 27(2): 189-195. doi: 10.1089/end.2012.0394

    [30]

    Busby JE, Brown GA, Matin SF. Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic[J]. Urology, 2008, 71(3): 413-416. doi: 10.1016/j.urology.2007.10.028

    [31]

    Abe T, Takada N, Matsumoto R, et al. Outcome of regional lymphadenectomy in accordance with primary tumor location on laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study[J]. J Endourol, 2015, 29(3): 304-309. doi: 10.1089/end.2014.0369

    [32]

    Joseph JP, O'Malley P, Su LM. Robot-assisted radical nephroureterectomy[J]. J Endourol, 2021, 35(s2): S122-S131. doi: 10.1089/end.2020.1074

    [33]

    Lanfranco AR, Castellanos AE, Desai JP, et al. Robotic surgery: a current perspective[J]. Ann Surg, 2004, 239(1): 14-21. doi: 10.1097/01.sla.0000103020.19595.7d

    [34]

    丁国庆, 王平, 叶烈夫, 等. 机器人辅助腹腔镜治疗上尿路尿路上皮癌专家共识[J]. 微创泌尿外科杂志, 2024, 13(2): 87-92.

    [35]

    Hemal AK, Stansel I, Babbar P, et al. Robotic-assisted nephroureterectomy and bladder cuff excision without intraoperative repositioning[J]. Urology, 2011, 78(2): 357-364. doi: 10.1016/j.urology.2010.12.075

    [36]

    俞世成, 朱世斌, 胡海义, 等. 单一体位单次锚定机器人辅助腹腔镜肾输尿管全长切除术62例临床分析[J]. 中华外科杂志, 2021, 59(6): 530-534.

    [37]

    Solano C, Corrales M, Keller EX, et al. Comparison of European and American guidelines for upper tract urothelial carcinoma: how are they different?[J]. J Endourol, 2024, 38(5): 488-498. doi: 10.1089/end.2023.0476

  • 加载中
计量
  • 文章访问数:  540
  • PDF下载数:  63
  • 施引文献:  0
出版历程
收稿日期:  2023-10-23
修回日期:  2024-09-29
刊出日期:  2024-11-06

目录